Form 4: UnitedHealth Group Director Acquires 190 Shares of Common Stock as Deferred Compensation

Sentiment:

SEC Form 4 Filing


Frederick William McNabb III, a director at UnitedHealth Group, acquired 190 shares of common stock as deferred compensation on January 2, 2025.

Summary

  • Frederick William McNabb III, a director of UnitedHealth Group, acquired 190 shares of common stock on January 2, 2025.
  • These shares were granted as deferred stock units, representing regular quarterly compensation for his service as a director.
  • The deferred stock units are immediately vested but must be retained until the director completes their service on the board.
  • Following this transaction, Mr. McNabb beneficially owns 13,443 shares of UnitedHealth Group common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively. It indicates alignment of interests between the director and shareholders.

Positives

  • The acquisition of shares by a director demonstrates alignment of interests with shareholders.
  • The deferred stock units are immediately vested, indicating a commitment to the director's long-term service.

Industry Context

This is a routine transaction related to director compensation, which is common practice in publicly traded companies. It aligns the director's interests with those of the shareholders.

Comparison to Industry Standards

  • Director compensation in the form of stock grants is a common practice among large publicly traded companies like UnitedHealth Group.
  • Companies such as CVS Health, Anthem, and Humana also use similar methods to compensate their directors, often with a mix of cash and equity.
  • The vesting and holding requirements for these stock grants are also typical, ensuring directors have a long-term stake in the company's performance.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders by aligning director interests with company performance.
  • The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
01/02/2025Date of the transaction where 190 shares of common stock were acquired.
01/06/2025Date the Form 4 was signed by the Attorney-in-Fact.

Keywords

UnitedHealth Group, Director, Stock Acquisition, Deferred Stock Units, Compensation, Beneficial Ownership, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.